UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.099

Sortiert nach

Reference interval establishment and correlation research of urine thromboxane metabolites: Unveiling new possibilities in platelet activation

Clinica chimica acta, 2024-05, Vol.558, p.119672-119672, Article 119672

2024

Link zum Volltext

Verfügbarkeit prüfen

Relationship of PCSK9 and Urinary Thromboxane Excretion to Cardiovascular Events in Patients With Atrial Fibrillation

Journal of the American College of Cardiology, 2017-09, Vol.70 (12), p.1455-1462

2017

Link zum Volltext

Verfügbarkeit prüfen

Reversal of the anti‐platelet effects of aspirin and clopidogrel

Journal of thrombosis and haemostasis, 2012-04, Vol.10 (4), p.521-528

2012

Link zum Volltext

Verfügbarkeit prüfen

Incomplete Inhibition of Thromboxane Biosynthesis by Acetylsalicylic Acid : Determinants and Effect on Cardiovascular Risk

Circulation (New York, N.Y.), 2008-10, Vol.118 (17), p.1705-1712

2008

Link zum Volltext

Verfügbarkeit prüfen

Pharmacodynamic effects of indobufen compared with aspirin in patients with coronary atherosclerosis

European journal of clinical pharmacology, 2021-12, Vol.77 (12), p.1815-1823

2021

Link zum Volltext

Verfügbarkeit prüfen

The contribution of cyclooxygenase-1 and -2 to persistent thromboxane biosynthesis in aspirin-treated essential thrombocythemia: implications for antiplatelet therapy

Blood, 2010-02, Vol.115 (5), p.1054-1061

2010

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of dose-related effects of aspirin on platelet function : Results from the aspirin-induced platelet effect (ASPECT) study

Circulation (New York, N.Y.), 2007-06, Vol.115 (25), p.3156-3164

2007

Link zum Volltext

Verfügbarkeit prüfen

Oxidant stress as a major determinant of platelet activation in invasive breast cancer

International journal of cancer, 2017-02, Vol.140 (3), p.696-704

2017

Link zum Volltext

Verfügbarkeit prüfen

The intake of broccoli sprouts modulates the inflammatory and vascular prostanoids but not the oxidative stress-related isoprostanes in healthy humans

Food chemistry, 2015-04, Vol.173, p.1187-1194

2015

Link zum Volltext

Verfügbarkeit prüfen

Platelet activation in type 2 diabetes mellitus

Journal of thrombosis and haemostasis, 2004-08, Vol.2 (8), p.1282-1291

2004

Link zum Volltext

Verfügbarkeit prüfen

Transformation of Prostaglandin D 2 to 11-Dehydro Thromboxane B 2 by Baeyer-Villiger Oxidation

Lipids, 2020-01, Vol.55 (1), p.73-78

2020

Link zum Volltext

Verfügbarkeit prüfen

Oxidative damage, platelet activation, and inflammation to predict mobility disability and mortality in older persons: results from the health aging and body composition study

The journals of gerontology. Series A, Biological sciences and medical sciences, 2012-06, Vol.67 (6), p.671-676

2012

Link zum Volltext

Verfügbarkeit prüfen

Twice daily dosing of aspirin improves platelet inhibition in whole blood in patients with type 2 diabetes mellitus and micro- or macrovascular complications

Thrombosis and haemostasis, 2011-09, Vol.106 (3), p.491

2011

Link zum Volltext

Verfügbarkeit prüfen

Moderate oral supplementation with docosahexaenoic acid improves platelet function and oxidative stress in type 2 diabetic patients

Thrombosis and haemostasis, 2015-08, Vol.114 (2), p.289

2015

Link zum Volltext

Verfügbarkeit prüfen

Untargeted metabolomics reveals alterations in metabolites of lipid metabolism and immune pathways in the serum of rats after long-term oral administration of Amalaki rasayana

Molecular and cellular biochemistry, 2020-01, Vol.463 (1-2), p.147-160

2020

Link zum Volltext

Verfügbarkeit prüfen

Association of cyclooxygenase-2 genetic variant with cardiovascular disease

European heart journal, 2014-09, Vol.35 (33), p.2242-2248

2014

Link zum Volltext

Verfügbarkeit prüfen

Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events

Circulation (New York, N.Y.), 2002-04, Vol.105 (14), p.1650-1655

2002

Link zum Volltext

Verfügbarkeit prüfen

Urinary 11-dehydro-thromboxane B2 levels are associated with vascular inflammation and prognosis in atherosclerotic cardiovascular disease

Prostaglandins & other lipid mediators, 2018-01, Vol.134, p.24-31

2018

Link zum Volltext

Verfügbarkeit prüfen

Kidney Transplantation in a Patient Lacking Cytosolic Phospholipase A 2 Proves Renal Origins of Urinary PGI-M and TX-M

Circulation research, 2018-02, Vol.122 (4), p.555-559

2018

Link zum Volltext

Verfügbarkeit prüfen

Urinary 11-Dehydro-Thromboxane B 2 and Mortality in Patients With Stable Coronary Artery Disease

The American journal of cardiology, 2017-04, Vol.119 (7), p.972-977

2017

Link zum Volltext

Verfügbarkeit prüfen

Antiplatelet Effect Durability of a Novel, 24-hour, Extended-Release Prescription Formulation of Acetylsalicylic Acid in Patients With Type 2 Diabetes Mellitus

The American journal of cardiology, 2016-12, Vol.118 (12), p.1941-1947

2016

Link zum Volltext

Verfügbarkeit prüfen

Hydrogen sulphide pathway contributes to the enhanced human platelet aggregation in hyperhomocysteinemia

Proceedings of the National Academy of Sciences - PNAS, 2013-09, Vol.110 (39), p.15812-15817

2013

Link zum Volltext

Verfügbarkeit prüfen

Urinary 11‐dehydrothromboxane B2 aspirin efficacy testing is sensitive to perioperative inflammation in pediatric solid‐organ transplant patients

Pediatric blood & cancer, 2022-02, Vol.69 (2), p.e29413-n/a

2022

Link zum Volltext

Verfügbarkeit prüfen

Urinary 11-dehydro-thromboxane B2 is associated with cardiovascular events and mortality in patients with atrial fibrillation

The American heart journal, 2015-09, Vol.170 (3), p.490-497.e1

2015

Link zum Volltext

Verfügbarkeit prüfen

Reduced Variability to Aspirin Antiplatelet Effect by the Coadministration of Statins in High‐Risk Patients for Cardiovascular Disease

Clinical pharmacology and therapeutics, 2018-07, Vol.104 (1), p.111-119

2018

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 1.099

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(955)
Mit Volltextzugriff
(820)

Publikationsform

Artikel
(1.099)

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(778)
Life Sciences & Biomedicine
(756)
Humans
(707)
Male
(662)
Biological And Medical Sciences
(524)
Thromboxane B2 - Analogs & Derivatives
(524)
Female
(514)
Thromboxane B2 - Urine
(468)
Animals
(441)
Medical Sciences
(401)
Thromboxane B2 - Blood
(327)
Adult
(322)
Middle Aged
(294)
Aged
(199)
Thromboxane B2 - Metabolism
(198)
Cardiovascular System & Cardiology
(196)
Platelet Aggregation - Drug Effects
(176)
Pharmacology. Drug Treatments
(175)
Rats
(173)
6-Ketoprostaglandin F1 Alpha - Urine
(155)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Reference interval establishment and correlation research of urine thromboxane metabolites: Unveiling new possibilities in platelet activation

Relationship of PCSK9 and Urinary Thromboxane Excretion to Cardiovascular Events in Patients With Atrial Fibrillation

Reversal of the anti‐platelet effects of aspirin and clopidogrel

Incomplete Inhibition of Thromboxane Biosynthesis by Acetylsalicylic Acid : Determinants and Effect on Cardiovascular Risk

Pharmacodynamic effects of indobufen compared with aspirin in patients with coronary atherosclerosis

The contribution of cyclooxygenase-1 and -2 to persistent thromboxane biosynthesis in aspirin-treated essential thrombocythemia: implications for antiplatelet therapy

Evaluation of dose-related effects of aspirin on platelet function : Results from the aspirin-induced platelet effect (ASPECT) study

Oxidant stress as a major determinant of platelet activation in invasive breast cancer

The intake of broccoli sprouts modulates the inflammatory and vascular prostanoids but not the oxidative stress-related isoprostanes in healthy humans

Platelet activation in type 2 diabetes mellitus

Transformation of Prostaglandin D 2 to 11-Dehydro Thromboxane B 2 by Baeyer-Villiger Oxidation

Oxidative damage, platelet activation, and inflammation to predict mobility disability and mortality in older persons: results from the health aging and body composition study

Twice daily dosing of aspirin improves platelet inhibition in whole blood in patients with type 2 diabetes mellitus and micro- or macrovascular complications

Moderate oral supplementation with docosahexaenoic acid improves platelet function and oxidative stress in type 2 diabetic patients

Untargeted metabolomics reveals alterations in metabolites of lipid metabolism and immune pathways in the serum of rats after long-term oral administration of Amalaki rasayana

Association of cyclooxygenase-2 genetic variant with cardiovascular disease

Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events

Urinary 11-dehydro-thromboxane B2 levels are associated with vascular inflammation and prognosis in atherosclerotic cardiovascular disease

Kidney Transplantation in a Patient Lacking Cytosolic Phospholipase A 2 Proves Renal Origins of Urinary PGI-M and TX-M

Urinary 11-Dehydro-Thromboxane B 2 and Mortality in Patients With Stable Coronary Artery Disease

Antiplatelet Effect Durability of a Novel, 24-hour, Extended-Release Prescription Formulation of Acetylsalicylic Acid in Patients With Type 2 Diabetes Mellitus

Hydrogen sulphide pathway contributes to the enhanced human platelet aggregation in hyperhomocysteinemia

Urinary 11‐dehydrothromboxane B2 aspirin efficacy testing is sensitive to perioperative inflammation in pediatric solid‐organ transplant patients

Urinary 11-dehydro-thromboxane B2 is associated with cardiovascular events and mortality in patients with atrial fibrillation

Reduced Variability to Aspirin Antiplatelet Effect by the Coadministration of Statins in High‐Risk Patients for Cardiovascular Disease

Suchergebnisse filtern